Tempus launches major Covid testing and data initiative to fight the coronavirus

Tempus, a Chicago precision medicine startup best known for its genomic sequencing technology that helps create better and more personalized treatment plans for cancer patients, is among the many high-tech businesses now pivoting its mission to combat the raging Covid-19 pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.